As of 2025-03-15, the Relative Valuation of Shield Therapeutics PLC (STX.L) is (56.24) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3.00 GBP, the upside of Shield Therapeutics PLC based on Relative Valuation is -1974.8%.
The range of the Relative Valuation is (48.19) - (59.58) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 19.2x | 16.4x |
| Forward P/E multiples | 13.6x - 17.2x | 16.0x |
| Fair Price | (48.19) - (59.58) | (56.24) |
| Upside | -1706.3% - -2085.9% | -1974.8% |
| Date | P/E |
| 2025-03-07 | -1.01 |
| 2025-03-06 | -0.99 |
| 2025-03-05 | -0.97 |
| 2025-03-04 | -0.99 |
| 2025-03-03 | -0.95 |
| 2025-02-28 | -0.95 |
| 2025-02-27 | -0.95 |
| 2025-02-26 | -0.99 |
| 2025-02-25 | -1.04 |
| 2025-02-24 | -0.93 |
| 2025-02-21 | -1.04 |
| 2025-02-20 | -1.09 |
| 2025-02-19 | -1.09 |
| 2025-02-18 | -1.05 |
| 2025-02-17 | -1.11 |
| 2025-02-14 | -1.17 |
| 2025-02-13 | -1.09 |
| 2025-02-12 | -1.11 |
| 2025-02-11 | -1.07 |
| 2025-02-10 | -1.01 |
| 2025-02-07 | -0.86 |
| 2025-02-06 | -0.89 |
| 2025-02-05 | -0.97 |
| 2025-02-04 | -0.82 |
| 2025-02-03 | -0.78 |
| 2025-01-31 | -0.81 |
| 2025-01-30 | -0.78 |
| 2025-01-29 | -0.78 |
| 2025-01-28 | -0.84 |
| 2025-01-27 | -0.84 |
| 2025-01-24 | -0.86 |
| 2025-01-23 | -0.81 |
| 2025-01-22 | -0.70 |
| 2025-01-21 | -0.68 |
| 2025-01-20 | -0.68 |
| 2025-01-17 | -0.68 |
| 2025-01-16 | -0.70 |
| 2025-01-15 | -0.65 |
| 2025-01-14 | -0.67 |
| 2025-01-13 | -0.68 |
| 2025-01-10 | -0.72 |
| 2025-01-09 | -0.76 |
| 2025-01-08 | -0.76 |
| 2025-01-07 | -0.77 |
| 2025-01-06 | -0.77 |
| 2025-01-03 | -0.78 |
| 2025-01-02 | -0.76 |
| 2024-12-31 | -0.78 |
| 2024-12-30 | -0.76 |
| 2024-12-27 | -0.78 |